Clinical trial

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

NCT02506777

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-07-01

PhasePHASE2

Study timeline

Study start (unknown)2015-07-01Date precision: month

Registry last updated2019-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

metforminDRUG · verified · RxNorm: metformin

FluoruracilDRUG

DoxorubicinDRUG · verified · RxNorm: doxorubicin

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

melatoninDRUG · verified · RxNorm: melatonin

Sponsors & collaborators

N.N. Petrov National Medical Research Center of Oncologylead sponsor

Mapped research locations

Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02506777 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.